ask="N/A"
ask_size="N/A"
average_daily_volume="235"
bid="N/A"
bid_size="N/A"
book_value="3.9850"
change="+0.0001"
change_from_200_day_moving_average="-0.0876"
change_from_50_day_moving_average="0.3280"
change_from_52_week_high="-4.6799"
change_From_52_week_low="3.0101"
change_in_percent="+0.0015%"
close="6.6101"
dividend_pay_date="2/1/2017"
dividend_per_share="0.6000"
dividend_yield="9.0800"
earnings_per_share="-4.0560"
ebitda="-14.68M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="1/13/2017"
float_shares="3373000"
high="6.6101"
high_52_weeks="11.2900"
last_trade_date="1/24/2017"
last_trade_price="6.6101"
last_trade_size="100"
last_trade_time="10:34am"
low="6.6100"
low_52_weeks="3.6000"
market_capitalization="28.10M"
moving_average_200_day="6.6977"
moving_average_50_day="6.2821"
name="Cyclacel Pharmaceuticals
Inc. "
notes="N/A"
one_year_target_price="N/A"
open="6.6100"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-1.3075%"
percent_change_from_50_day_moving_average="+5.2208%"
percent_change_from_52_week_high="-41.4517%"
percent_change_from_52_week_low="+83.6139%"
previous_close="6.6100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.6587"
price_per_sales="28.4692"
revenue="986999.00"
shares_outstanding="4251000"
short_ratio="0.4300"
stock_exchange="NCM"
symbol="CYCCP"
volume="1030"
weeks_range_52="3.6000 - 11.2900"
